Differences in drug prescribing patterns in elderly parkinsonian patients identified at hospital admission

Pharmacy World and Science

Volumn 19, Issue 6, 1997, Pages 275-278

  Trewin, V F ^a   Lawrence, C J ^b   Abdulla, A J J ^a   Pearce, V R ^a   Veitch, G B A ^c   Roach, M ^d  

^a Roy Devon Exeter Hlthcare NHS T ^*  (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c UNIVERSITY OF WALES   (United Kingdom)

^d Roy Devon Exeter Hlthcare Trust   (United Kingdom)

Author keywords

Elderly; Parkinson's disease; Prescribing patterns

Indexed keywords

ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIGOXIN; DIURETIC AGENT; HYPNOTIC AGENT; LAXATIVE; LEVODOPA; NEUROLEPTIC AGENT; ORGANIC NITRATE;

AGED; ARTICLE; BRADYKINESIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PARKINSON DISEASE; PRESCRIPTION; PROGNOSIS; QUALITY OF LIFE; RIGIDITY; STATISTICS; TREMOR;

AGED; AGED, 80 AND OVER; DRUG UTILIZATION; FEMALE; GREAT BRITAIN; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PRESCRIPTIONS, DRUG;

EID: 0030727479     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008669826178     Document Type: Article

References (14)

1. Lawrence CJ, Trewin VF. Statistical methods in the construction of pharmacological reference ranges and their use in the identification of adverse drug reactions. Statist Applic 1990;2(4):333-49.
2. Trewin VF. The design of an algorithm for pharmacists to evaluate ADRs in the Elderly. J Clin Pharm & Therap 1991;16:45-53.
3. Duvoisin RC. Parkinson's Disease: A guide for patients and family. Raven Press: New York, 1978.
4. Montastruc JL, Chamontin B, Rascol A. Parkinson's disease and hypertension: Chronic bromocriptine treatment. Neurol. (Minneap.) 1985;35:1644-7.
5. Ziegler MG, Kennedy B, Holland OB et al. The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems. Int J Clin Ther Toxicol 1985;23:175-9.
6. Iwasaki S, Hamaguchi K, Iwasaki A et al. Hypotensive effect of long-term levodopa in patients with Parkinson's disease. Europ Neurol 1990;30:194-9.
7. Durrieu G, Senard, JM, Tran MA et al. Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in Parkinsonians. Clin Neuropharmacol 1991;14:84-90.
8. Micieli G, Martignoni E, Bono G et al. A study of the cardiopressor effects of lisuride in the treatment of Parkinsonism and Pathological Ageing Brain. Clin Neuropharmacol 1989;12(5):404-15.
9. Abu-Jayyab AR. Insights on the mechanism of action of bromocriptine. J Pharm Med 1991;1:185-94.
10. Ramsay LE, Yeo WW, Jackson PR. Diabetes, impaired glucose tolerance and insulin resistance with diuretics. Europ Heart J 1992;13:68-71.
11. Sweet RD, McDowell FH. Five years' treatment of Parkinson's disease with levodopa. Ann Int Med 1975;83:456-63.
12. Berg MJ, Ebert B, Willis DK et al. Parkinsonism - Drug treatment: Part 1. Drug Intell Clin Pharm 1987;21:10-21.
13. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17(5):427-42.
14. Baldwin RC, Byrne EJ. Psychiatric aspects of Parkinson's disease. Br Med J 1989;299:3-4.